Please assess the completion status of the following clinical trial:

Trial Title: Intermittent Preventive Treatment With Antimalarials in Kenyan Infants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Presenting for Pentavalent 1 immunization~* Age 5 weeks to 16 weeks~* Parent or guardian currently resident in study catchment area~* Parent or guardian has given permission for their child to participate~Exclusion Criteria:~* Known allergy to any of the study drugs~* Current Cotrimoxazole prophylaxis~* Concomitant disease requiring hospitalization or transfusion~* Plans to be away from the study area for more than 6 months during the next year

- Gender: ALL
- Minimum Age: 5 Weeks
- Maximum Age: 16 Weeks
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).